Philadelphia Drug Exchange

Nonprofit profile at a glance

EIN
236294316
IRS 990-EZ coverage
2018–2025
Forms available
Form 990-EZ 2025, Form 990-N 2023
Location
West Chester, PA, USA
Phone
4844670999
Rating
39
Verdict
REVIEW
Rating confidence
Moderate

Official website

Reported finances

Revenue
$26,204
Expenses
$22,345
Assets
$11,227

Source: IRS Form 990-EZ. Selected filing: tax year 2025. Amounts in USD.

Leadership & pay

7 people listed

Executive titles in this filing

  • Susan Stipa (Vice President (Volunteer))
  • Phil Milia (President (Volunteer))
  • Susan Stipa (Vice President (Volunteer))
  • Phil Milia (President (Volunteer))

People named in this filing

  • Susan Stipa (Vice President (Volunteer))
  • Phil Milia (President (Volunteer))
  • Nicholas Charles DelBonifro (Treasurer (Volunteer))

Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.

Source: IRS Form 990-EZ. Selected filing: tax year 2025. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

Purpose of the PDE is to promote and network within the health science and pharmaceutical industry

What it reported doing in 2025

Scholarship

Operating model

Revenue model
Membership-supported. 87% of the money available for current operations came from membership dues.
Distribution model
Grant intermediary. The nonprofit sent 100% of its reported program spending out as grants.

The verdict

REVIEW - The filed numbers largely add up. A relatively small share of available resources goes toward mission work and a relatively small share of total spending goes to programs.

Rating breakdown

  • Financial Efficiency: 8
  • Transparency & Controls: 82
  • Sustainability: 41
  • Growth: 0

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 7.6%; rating input score 8
  • Program expense ratio: 9%; rating input score 9

Transparency & Controls

  • Consistency checks: 100%; rating input score 100; 51st percentile among comparable filings
  • Major donor itemization: Limited

Sustainability

  • Operating margin: 14.7%; rating input score 66; 66th percentile among comparable filings
  • Total-asset coverage ratio: 0.5; rating input score 31; 31st percentile among comparable filings
  • Liabilities to assets ratio: Limited
  • Officer compensation ratio: 52.6%; rating input score 3; 3rd percentile among comparable filings

Growth

  • Program expense growth: -15.2% per year; rating input score 0; 23rd percentile among comparable filings
  • Revenue growth: -0.1% per year; rating input score 0; 49th percentile among comparable filings
  • Asset growth: -27.8% per year; rating input score 0; 8th percentile among comparable filings

Details

  • Where the money goes: 7.6% of revenue deployed · 9% of spending went to programs
  • Governance: Filed governance answers
  • Accomplishments: 1 filed program accomplishment · $2K in reported program spending
  • Leadership: top reported pay $0 · 7 people listed
  • Consistency: 7 of 7 current checks pass
  • Schedules: 1 filed schedules
  • Filing history: 6 filing years from 2018 to 2025
  • Contacts: How to reach this organization
  • Money network: 1 filed money-flow record
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • High — Financial Efficiency: Mission deployment rate scored 8/100.
  • High — Financial Efficiency: Program expense ratio scored 9/100.
  • High — Growth: Program expense growth scored 0/100.
  • High — Growth: Revenue growth scored 0/100.
  • Moderate — Sustainability: Total-asset coverage ratio scored 31/100.
  • High — Growth: Asset growth scored 0/100.
  • High — Sustainability: Officer compensation ratio scored 3/100.